secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001493152-25-020718
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD Q3 revenue record $2.5M (+39% YoY) as U.S. CGuard Prime launch gains traction
--------------------------------------------------------------------------------

- U.S. revenue of $497k marks first commercial quarter for CGuard Prime carotid stent system.
- Net loss $12.7M ($0.17/share) vs $7.9M ($0.16) a year ago; operating expenses up 57% on U.S. expansion.
- Cash and marketable securities $63.4M at Sep 30, up from $34.6M at Dec 31, 2024, boosted by $58M July offering.
- Over 100 U.S. carotid procedures completed; appointed Peter A. Soukas, M.D. as CMO and Dan Dearen to board.
- Gross profit nearly doubled to $864k on favorable shift toward higher-margin U.S. sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315225020718/0001493152-25-020718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315225020718/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer